A 10-gene signature can now predict recurrence risk for HR+/HER2- early breast cancer #EBC patients post-chemo-endocrine therapy.
@myesmo.bsky.social @breastcancerorg.bsky.social
#Onco404 #Cancer #Kanser #BreastCancer #MemeKanseri #OncotypeDX #MammaPrint #EndoPredict #Prosigna #PAM50 #GGI #MedSky
1
1
1
0